MART-1 Recombinant monoclonal antibody (rMLANA/788)

Flow Cytometry (0.5-1 μg/106 cells in 0.1 mL) Immunofluorescence (0.5-1 μg/mL) Immunohistochemistry (formalin-fixed paraffin sections) (0.5-1 μg/mL for 30 min at RT) Western blot (0.5-1 μg/mL) Suggested dilutions/conditions may not be available for all applications.Optimal conditions must be determined individually for each application.

This mAb labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. It does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.